Healthequity (HQY) Long-Term Investments (2019)
Healthequity's (HQY) quarterly Long-Term Investments came in at $81.8 million in Q3 2019, up 4.83% quarter-over-quarter from $78.1 million in Q2 2019.
Healthequity (HQY) Long-Term Investments (2019) Analysis & Trends
Healthequity's Long-Term Investments history runs 1 years deep, the most recent figure standing at $81.8 million for Q3 2019.
- On a quarterly basis, Long-Term Investments changed N/A year-over-year to $81.8 million in Q3 2019; TTM through Jul 2019 was $81.8 million, a N/A change from a year earlier, with the FY2019 full-year figure at $709000.0, changed N/A from the prior year.
- Long-Term Investments grew to $81.8 million in Q3 2019 per HQY's latest filing, from $78.1 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $81.8 million in Q3 2019 and bottomed at $709000.0 in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 29.34 Bn | 22.03 Bn | 662.02 Mn | - |
| 2 | BrightSpring Health Services | 13.49 Bn | 12.59 Bn | 482.22 Mn | 7.49 Mn |
| 3 | Healthequity | 7.96 Bn | 7.70 Bn | 256.31 Mn | - |
| 4 | 10x Genomics | 6.17 Bn | 5.63 Bn | 106.18 Mn | - |
| 5 | Hinge Health | 6.02 Bn | 5.70 Bn | 154.23 Mn | 89.77 Mn |
| 6 | MiniMed | 4.19 Bn | 3.89 Bn | 480.00 Mn | - |
| 7 | Waystar Holding | 4.14 Bn | 4.07 Bn | 216.84 Mn | - |
| 8 | Doximity | 3.82 Bn | 3.08 Bn | 125.97 Mn | - |
| 9 | Privia Health | 3.10 Bn | 2.73 Bn | - | - |
| 10 | Omnicell | 1.81 Bn | 1.57 Bn | 140.36 Mn | 58.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2019 | 81.84 Mn |
| Apr 30, 2019 | 78.07 Mn |
| Jan 31, 2019 | 709,000.00 |